These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1583066)

  • 1. Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice.
    Pimm MV; Robins RA; Baldwin RW
    J Cancer Res Clin Oncol; 1992; 118(5):367-70. PubMed ID: 1583066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
    Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
    Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumour therapy of solid tumours with ricin-antibody conjugates.
    Kanellos J; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():89-99. PubMed ID: 2786496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells.
    Levin LV; Griffin TW; Childs LR; Davis S; Haagensen DE
    Cancer Immunol Immunother; 1987; 24(3):202-6. PubMed ID: 3496151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
    Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chronic lymphocytic leukemia antigen (cCLLa) as immunotherapy target: pharmacokinetics and biodistribution of two divalent, ricin-based immunotoxins in xenografted athymic mice.
    Faguet GB; Agee JF
    Leuk Lymphoma; 1997 May; 25(5-6):509-20. PubMed ID: 9250822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
    Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
    Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.
    LoRusso PM; Lomen PL; Redman BG; Poplin E; Bander JJ; Valdivieso M
    Am J Clin Oncol; 1995 Aug; 18(4):307-12. PubMed ID: 7625372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy.
    Yanagië H; Tomita T; Kobayashi H; Fujii Y; Nonaka Y; Saegusa Y; Hasumi K; Eriguchi M; Kobayashi T; Ono K
    Br J Cancer; 1997; 75(5):660-5. PubMed ID: 9043021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine.
    Smith W; Gore VA; Brandon DR; Lynch DN; Cranstone SA; Corvalan JR
    Cancer Immunol Immunother; 1990; 31(3):157-63. PubMed ID: 2186853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.
    Pimm MV; Perkins AC; Baldwin RW
    Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo localization of radiolabeled monoclonal antibody to carcinoembryonic antigen (CEA) in a CEA-producing tumor--comparison with polyclonal antibody.
    Kamei T; Seto H; Taki K; Soya T; Kakishita M; Maeda M; Honda T; Koshimura S
    Radioisotopes; 1987 Jan; 36(1):14-9. PubMed ID: 3562906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F; Faibre-Chauvet A; Saï-Maurel C; Gautherot E; Fiche M; Campion L; Le Boterff J; Barbet J; Chatal JF; Thédrez P
    J Nucl Med; 1999 Jan; 40(1):198-204. PubMed ID: 9935077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
    Wang ZF; Stein R; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
    Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotypic monoclonal antibody AB3, reacting with the primary antigen (CEA), can localize in human colon-carcinoma xenografts as efficiently as AB1.
    de Moraes JZ; Gesztesi JL; Westermann P; Le Doussal JM; Lopes JD; Mach JP
    Int J Cancer; 1994 May; 57(4):586-91. PubMed ID: 8181861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.
    Trown PW; Reardan DT; Carroll SF; Stoudemire JB; Kawahata RT
    Cancer Res; 1991 Aug; 51(16):4219-25. PubMed ID: 1868442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.